Michael H. Kershaw
Michael H. Kershaw received his Ph.D. degree in immunology from the University of Melbourne, Australia in 1997. He then undertook a Postdoctoral position in the surgery branch at the National Cancer Institute, Bethesda, Maryland. In 2002, Michael returned to Melbourne to take up a position leading the Cancer Immunotherapy Research Laboratory at the Peter MacCallum Cancer Centre. His main interest is in developing adoptive immunotherapies for cancer. In particular, Michael's interest lies in using genetic modification of lymphocytes to generate T cells reactive against a variety of malignancies. His most recent work involves using genetically redirected T cells specific for the tumor-associated antigen, Lewis-Y, for the treatment of patients with acute myeloid leukemia.
Biography Updated on 4 September 2011